The ESE acts as the voice of its members on the issues that matter to them. We actively engage in advocacy: encouraging government organisations to better support the needs of our members.
In order to best represent them, ESE actively seeks the views of its members across Europe. The ESE Council of Affiliated Societies (ECAS) provides a forum for our National Affiliated Societies. ECAS helps us to understand opportunities, challenges and developments, and initiate pan-European programmes benefiting endocrinology.
The European Society of Endocrinology represents more than 20 000 endocrinologists through direct membership and affiliated societies. We amplify these voices by combining influence with other societies as a member of collaborative advocacy groups. Through our association with Alliance for Biomedical Research in Europe, Initiative for Science in Europe and the European Medicines Agency, we hope to drive real change in policy and improve opportunities available to endocrine researchers throughout Europe.
As we increase our advocacy activity we plan to narrow our focus towards the issues that have greatest effect on our members. We will regularly update you about our activities and ensure that interested parties have the chance to provide their input.
ESE: The Voice for Endocrinology
ESE’s Mission Statement -‘Shaping the Future of Endocrinology’ - requires that we actively engage with different stakeholders in creating a European and broader international environment that recognises the important place of ‘endocrine’ health in the development of future health care policies and support to research programmes.
- ESE: The Voice for Endocrinology
- ESE & Policy and Advocacy
- ESE & COVID-19 and EU4Health
- ESE & Endocrine Disrupting Chemicals in the EU
- ESE & EU Beating Cancer Plan
If you want to become more engaged in ESE Policy and Advocacy activities please complete this form.
ESE & COVID-19 and EU4Health.
ESE’s experts have been very active since the pandemic started, identifying links between COVID-19 and endocrinology. Our latest position paper on the topic can be found here. Recently (15 February 2021) Member of the European Parliament (MEP) Sirpa Pietikäinen (Finland, European People’s Party) echoed our call for a stronger policy response in the Parliament Magazine. Read her article here.
ENDOCRINE DISRUPTING CHEMICALS
ESE's EDC Working Group has been very active since 2019. You can follow ESE's activities on EDCs here.
ESE's Policy and Advocacy Working Group (launched in late 2019) have been following the European Commission's 'Beating Cancer Roadmap' with interest and presented a submission to this in March 2019.
ESE Statement following the publication of Europe’s Beating Cancer Plan on 3 February 2021: The European Society of Endocrinology (ESE) welcomes the European Commission Beating Cancer Plan, presented on 3 February 2021, ahead of World Cancer Day. A strong focus on cancer and holistic approach is needed to make a difference for the many people and their families suffering from this disease. The Beating Cancer Plan touches upon many of ESE’s key priorities - read more in our Statement.
ORGANISATIONS ESE IS WORKING WITH INCLUDE:
Read more about the organisations with which ESE is working to deliver its advocacy activities: